Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $31.45 | Total: $157.25 |
| 1 | 10 | $26.64 | Total: $266.40 |
| 1 | 25 | $22.57 | Total: $564.25 |
| 1 | 50 | $19.24 | Total: $962.00 |
| 1 | 100 | $16.65 | Total: $1,665.00 |
Overview
ML 315 is a selective Clk and DYRK inhibitor with potential anticancer activity for the study of neurological disorders.
Chemical Properties
| Molecular Formula | C18H13Cl2N3O2 |
| Molecular Weight | 374.22 |
| CAS Numbers | 1440251-53-5 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | ClC=1C=C(Cl)C=C(C1)CNC=2N=CN=CC2C3=CC=C4OCOC4=C3 |
Storage and Handling
0C Short Term, -20C Long Term
References
Coombs TC, et al. Small-molecule pyrimidine inhibitors of the cdc2-like [Clk] and dual specificity tyrosine phosphorylation-regulated [Dyrk] kinases development of chemical probe ML315. Bioorg Med Chem Lett. 2013 Jun 15;23[12] 3654-61.